Main > ONCOLOGY (**) > Lung>NSCLC>EGFR Exon20 Insertion+> > USA. J. EGF & MET Receptor MAb Inj

---

USA. J. EGF & MET Receptor MAb Inj's subsections
(*) USA Approval Date: 2021. 05.21
>MET
Companion Diagnostics: 2021. 12.09
Company
EGF: Epidermal Growth Factor
Generic Name: AmivantaMAb
MET: mesenchymal-epithelial transit
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 12.07
RTM
RTM Web-Site

USA. J. EGF & MET Receptor MAb Inj's products
This section has no products